Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 23, 2015, 76 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $179.66 to $12,841,992.00.

Highlighted Stocks Traded by Insiders:

Parexel International (PRXL) - FREE Research Report

Lindop Christopher J, who is Director at Parexel International, sold 2,000 shares at $63.59 on Feb. 23, 2015. Following this transaction, the Director owned 17,835 shares meaning that the stake was reduced by 10.08% with the 2,000-share transaction.

The shares most recently traded at $63.76, up $0.17, or 0.27% since the insider transaction. Historical insider transactions for Parexel International go as follows:

  • 4-Week # shares bought: 455
  • 4-Week # shares sold: 13,623
  • 12-Week # shares bought: 455
  • 12-Week # shares sold: 13,623
  • 24-Week # shares bought: 455
  • 24-Week # shares sold: 25,623

The average volume for Parexel International has been 586,600 shares per day over the past 30 days. Parexel International has a market cap of $3.5 billion and is part of the health care sector and health services industry. Shares are up 16.54% year-to-date as of the close of trading on Monday.

PAREXEL International Corporation is a biopharmaceutical outsourcing services company. The company has a P/E ratio of 23.9. Currently, there are 5 analysts who rate Parexel International a buy, no analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on PRXL - FREE

TheStreet Quant Ratings

rates Parexel International as a

buy

. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Parexel International Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Forward Air (FWRD) - FREE Research Report

Bell Rodney L, who is CFO, SVP & Treasurer at Forward Air, sold 2,523 shares at $54.00 on Feb. 23, 2015. Following this transaction, the CFO, SVP & Treasurer owned 94,181 shares meaning that the stake was reduced by 2.61% with the 2,523-share transaction.

The shares most recently traded at $53.48, down $0.52, or 0.97% since the insider transaction. Historical insider transactions for Forward Air go as follows:

  • 4-Week # shares sold: 3,533
  • 12-Week # shares sold: 3,533
  • 24-Week # shares sold: 3,533

The average volume for Forward Air has been 160,100 shares per day over the past 30 days. Forward Air has a market cap of $1.6 billion and is part of the services sector and transportation industry. Shares are up 7.07% year-to-date as of the close of trading on Monday.

Forward Air Corporation, together with its subsidiaries, provides surface transportation and related logistics services in North America. The company operates in three segments: Forward Air, Inc. (Forward Air), Forward Air Solutions, Inc. (FASI), and Total Quality, Inc. (TQI). The stock currently has a dividend yield of 0.89%. The company has a P/E ratio of 27.4. Currently, there are 2 analysts who rate Forward Air a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FWRD - FREE

TheStreet Quant Ratings

rates Forward Air as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Forward Air Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Autoliv (ALV) - FREE Research Report

Alspaugh Robert W, who is Director at Autoliv, sold 597 shares at $112.90 on Feb. 23, 2015. Following this transaction, the Director owned 3,747 shares meaning that the stake was reduced by 13.74% with the 597-share transaction.

The shares most recently traded at $112.93, up $0.03, or 0.03% since the insider transaction. Historical insider transactions for Autoliv go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 2,000

The average volume for Autoliv has been 561,200 shares per day over the past 30 days. Autoliv has a market cap of $10.1 billion and is part of the consumer goods sector and automotive industry. Shares are up 6.64% year-to-date as of the close of trading on Monday.

Autoliv, Inc., through its subsidiaries, develops, manufactures, and supplies automotive safety systems to the automotive industry worldwide. The company operates in two segments, Passive Safety and Active Safety segments. The stock currently has a dividend yield of 1.98%. The company has a P/E ratio of 22.4. Currently, there are 2 analysts who rate Autoliv a buy, 4 analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALV - FREE

TheStreet Quant Ratings

rates Autoliv as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

Autoliv Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null